PATENT CLAIM ANALYSIS

Application Number: 16100596
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "322000"]

Abstract:
Disclosed are chemical entities of Formula (I): wherein R 1  and Z are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of Formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of Formula (I).

Claim (Index 8):
The chemical entity of  claim 7 , wherein Z is a 6-membered monocyclic heteraromatic ring system having ring carbon atoms and 2 ring nitrogen atoms, wherein Z is substituted with 1 or 2 R x  groups.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 96.0
- Lexical Diversity: 1.65957
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15578460', '13820304', '14452729', '15548594', '15961553']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7892066773289814
- 35 USC 102 Novelty (BERT): 0.5985441433188468
- Combined Prediction Score: 0.770140423927968
- Mean Citation Score: 395.618496
- Max Citation Score: 596.97144
- Similarity Product: 426.6809908637952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test